Piper Sandler analyst issues NEUTRAL recommendation for BP on August 18, 2025 10:58AM ET. The previous analyst recommendation was Neutral.BP was trading at $34.33 at issue of the analyst recommendation.The...
Piper Sandler analyst issues OVERWEIGHT recommendation for COP on August 18, 2025 10:58AM ET. The previous analyst recommendation was Overweight.COP was trading at $95.33 at issue of the analyst recommendation.The...
Piper Sandler analyst issues OVERWEIGHT recommendation for CVX on August 18, 2025 10:59AM ET. The previous analyst recommendation was Overweight.CVX was trading at $156.55 at issue of the analyst recommendation.The...
Piper Sandler analyst issues OVERWEIGHT recommendation for XOM on August 18, 2025 11:00AM ET. The previous analyst recommendation was Overweight.XOM was trading at $106.49 at issue of the analyst recommendation.The...
Bernstein analyst issues OUTPERFORM recommendation for NKE on August 18, 2025 11:05AM ET. The previous analyst recommendation was Outperform.NKE was trading at $76.97 at issue of the analyst recommendation.The overall...
Morgan Stanley analyst issues OVERWEIGHT recommendation for NVDA on August 18, 2025 11:09AM ET. The previous analyst recommendation was Overweight.NVDA was trading at $180.45 at issue of the analyst recommendation.The...
Roth Capital analyst issues NEUTRAL recommendation for EQT on August 18, 2025 08:46AM ET. EQT was trading at $52.85 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current...
UBS analyst issues BUY recommendation for CVS on August 18, 2025 08:52AM ET. The previous analyst recommendation was Underperform.CVS was trading at $68.6 at issue of the analyst recommendation.The overall...
Goldman Sachs analyst issues NEUTRAL recommendation for TSLA on August 17, 2025 11:01AM ET. The previous analyst recommendation was Neutral.TSLA was trading at $330.56 at issue of the analyst recommendation.The...
Macquarie analyst issues OUTPERFORM recommendation for XPEV on August 15, 2025 05:39PM ET. The previous analyst recommendation was Outperform.XPEV was trading at $19.715 at issue of the analyst recommendation.The overall...
